DOTA-[Tyr3]-Octreotide Acid
* Please be kindly noted that our product can only be used for research to organizations or companies and not intended for individuals.
CAT#
R1831
CAS No.
177943-89-4
Explanation
DOTA-(Tyr3)-octreotate can be obtained through preparation of DOTA-containing peptides and radionucleotide complexes as antitumor agents for treating somatostatin postive tumor and metastasized tumors.
Synonyms/Alias
DOTATATE, DOTA-(Tyr³,Thr⁸)-Octreotide, DOTA-[Tyr3] Octreotide Acid (Octreotate); 4,7,10-Tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH acetate salt (Disulfide bond)
Molecular Formula
C65H90N14O19S2
M.W/Mr.
1435.63
Sequence
4,7,10-Tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH (disulfide bond)
Purity
98% by HPLC
Technical Data
Related Products
Useful Tools
Publications
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at .
We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry
